Date Time
Could treatment with a statin preserve brain function after COVID-19 infection?
A new clinical trial led by a UNSW Medicine & Health professor receives more than $2.3m in funding.
An innovative study to assess whether a commonly used cholesterol lowering medication can prevent brain complications from COVID-19 has received more than $2.3 million from the Medical Research Future Fund (MRFF).
The study is a collaboration between The George Institute for Global Health, UNSW Sydney, Monash University’s School of Public Health, University of Sydney and Sydney Local Health District. It is one of six clinical trials to begin in 2021 that have received grants totalling $10 million through the MRFF Clinical Trials Activity Initiative.
Getting control of COVID-19 will take more than widespread vaccination; it will also require a better understanding of why the disease causes no apparent symptoms in some people but leads to rapid multi-organ failure and death in others, as well as better insight into what treatments work best and for which patients.